Resumo
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- recurrent disease
- poor response to previous antibiotic therapy
- open comedones in intertriginous (axilla, groin, perineum, or infra-mammary) areas
- nodules or abscess
- symmetrical distribution
- sinus tracts with scarring
Other diagnostic factors
- premenstrual flare
Risk factors
- obesity
- female sex
- smoking
- positive family history
- African-American
Diagnostic investigations
Investigations to consider
- bacterial culture
- skin biopsy
Treatment algorithm
acute abscess
mild (Hurley stage I)
moderate (Hurley stage II)
severe (Hurley stage III)
Contributors
Авторы
David Cassarino, MD, PhD
Consultant Dermatopathologist
Southern California Permanente Medical Group
Los Angeles Medical Center
Los Angeles
CA
Раскрытие информации
DC declares that he has no competing interests.
Выражение благодарностей
Dr David Cassarino would like to gratefully acknowledge Dr Robert A. Lee, the previous contributor to this topic.
RAL declares that he has no competing interests.
Рецензенты
David R. Adams, MD, PharmD
Associate Professor of Dermatology
Penn State Hershey Medical Center
Hershey
PA
Disclosures
DRA declares that he has no competing interests.
Ravi Ubriani, MD, FAAD
Assistant Professor of Clinical Dermatology
Columbia University
New York
NY
利益声明
RU declares that he has no competing interests.
Andrew Carmichael, MB, BS
Consultant Dermatologist
James Cook University Hospital
Middlesbrough
UK
Declarações
AC declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Kim WB, Sibbald RG, Hu H, et al. Clinical features and patient outcomes of hidradenitis suppurativa: a cross-sectional retrospective study. J Cutan Med Surg. 2016;20:52-57.Texto completo Resumo
Martorell A, García-Martínez FJ, Jiménez-Gallo D, et al. An update on hidradenitis suppurativa (part I): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr. 2015;106:703-715.Texto completo Resumo
Sabat R, Jemec GBE, Matusiak Ł, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. Resumo
Martorell A, García FJ, Jiménez-Gallo D, et al. Update on hidradenitis suppurativa (part II): treatment. Actas Dermosifiliogr. 2015;106:716-724.Texto completo Resumo
Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422-34.Texto completo Resumo
Ingram JR, Woo PN, Chua SL, et al. Interventions for hidradenitis suppurativa. Cochrane Database Syst Rev. 2015;(10):CD010081.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Diagnósticos diferenciais
- Acne vulgaris
- Crohn's disease
- Inverse psoriasis
Mais Diagnósticos diferenciaisDiretrizes
- North American clinical management guidelines for hidradenitis suppurativa part II: Topical, intralesional, and systemic medical management
- Guidelines for the management of hidradenitis suppurativa (acne inversa)
Mais DiretrizesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer